Description: Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research in Europe, Asia, and the United States. It offers in-vitro diagnostic reagents for clinical chemistry analyzers. The company's products include the gentian calprotectin immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Cystatin C, a superior GFR marker for the diagnosis and therapeutic control of renal function; NT-proBNP Immunoassay for diagnosis, monitoring, and assessment of severity in individuals suspected of having congestive heart failure; and Canine c-reactive protein (CRP) immunoassay, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine CRP in dog plasma and serum. It also provides turbidimetric SARS-CoV-2 total antibody immunoassay, a quantitative antibody test for detecting antibodies targeting the S1-subunit. The company was incorporated in 2001 and is headquartered in Moss, Norway.
Home Page: www.gentian.com
Bjørnåsveien 5
Moss,
1596
Norway
Phone:
47 99 33 99 05
Officers
| Name | Title |
|---|---|
| Dr. Hilja Ibert | Chief Exec. Officer |
| Mr. Njaal Kind | CFO & COO |
| Mr. Erling Sundrehagen | Chief Scientific Officer |
| Mr. Markus Jaquemar | VP of Global Sales |
| Mr. Torsten Knüttel | VP of R&D |
Exchange: OL
Country: NO
Currency: Norwegian Krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.0465 |
| Price-to-Sales TTM: | 6.0093 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 50 |